Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D, L-lactide-co-glycolide) fibers

被引:44
作者
Crow, BB
Borneman, AF
Hawkins, DL
Smith, GM
Nelson, KD
机构
[1] Univ Texas, SW Med Ctr, Joint Program Biomed Engn, Dallas, TX 75230 USA
[2] Univ Texas, Dept Math, Arlington, TX 76019 USA
[3] Univ Kentucky, Dept Physiol, Albert B Chandler Med Ctr, Lexington, KY USA
[4] TissueGen Inc, Dallas, TX USA
来源
TISSUE ENGINEERING | 2005年 / 11卷 / 7-8期
关键词
D O I
10.1089/ten.2005.11.1077
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Biodegradable fibers of poly( (L)- lactic acid) ( PLLA) and poly( (D), (L)- lactide- co- glycolide) ( PLGA) that encapsulated a water- soluble drug were created by a patented technique consisting of wet- spinning a water- in- oil emulsion. These fibers are 2.4% by mass drug, which is slowly released, making these fibers potential candidates for implantation as drug delivery devices and/ or tissue- engineering substrates. Drug release kinetics and changes in molecular weight were investigated over time. This study demonstrated that drug release rates and molecular weight degradation are a function of the amount of aqueous phase added as an emulsion during fabrication. The type of polymer used ( PLLA or PLGA) determines the molecular weight degradation rates, but has little effect on drug release kinetics.
引用
收藏
页码:1077 / 1084
页数:8
相关论文
共 14 条
[1]  
Chasin M., 1990, Biodegradable Polymers as Drug Delivery Systems
[2]   Effects of solvent evaporation rate on the properties of protein-loaded PLLA and PDLLA microspheres fabricated by emulsion-solvent evaporation process [J].
Chung, TW ;
Huang, YY ;
Tsai, YL ;
Liu, YZ .
JOURNAL OF MICROENCAPSULATION, 2002, 19 (04) :463-471
[3]   Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles [J].
Crotts, G ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :123-134
[4]   Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis [J].
Igartua, M ;
Hernández, RM ;
Esquisabel, A ;
Gascón, AR ;
Calvo, MB ;
Pedraz, JL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 169 (01) :45-54
[5]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[6]   Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives [J].
Johansen, P ;
Men, Y ;
Audran, R ;
Corradin, G ;
Merkle, HP ;
Gander, B .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1103-1110
[7]  
Lu W, 1995, PDA J Pharm Sci Technol, V49, P13
[8]   Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres [J].
Meinel, L ;
Illi, OE ;
Zapf, J ;
Malfanti, M ;
Merkle, HP ;
Gander, B .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (1-2) :193-202
[9]   Technique paper for wet-spinning Poly(L-lactic acid) and poly(DL-lactide-co-glycolide) monofilament fibers [J].
Nelson, KD ;
Romero, A ;
Waggoner, P ;
Crow, B ;
Borneman, A ;
Smith, GM .
TISSUE ENGINEERING, 2003, 9 (06) :1323-1330
[10]  
NELSON KD, 2003, Patent No. 60147827